Biosimilars: Use as Indicated in Place of Our Current Biologic Therapies

08/07/2018

Related Content

Stress and Burnout
Stress and Burnout
Michael Niederman, MD, on How I Practice Now: How COVID-19 Has Changed the Outpatient Experience
09/18/2020
In part 1 of 3 of this video series, Pulmonology Consultant Advisory Board Member Michael Niederman, MD, discusses the long-lasting impacts that the COVID-19 pandemic will have on the outpatient experience....
09/18/2020
Inflammatory Bowel Disease
Kim Isaacs
Inflammatory Bowel Disease
Kim Isaacs, MD, on Management of Perianal Crohn Disease
09/12/2020
In this 2-minute video, Kim Isaacs, MD, discusses her presentation on managing perianal disease in patients with Crohn disease, which she gave at the September 12 virtual regional meeting of Advances in...
09/12/2020
Cardiometabolic Risk
Margo B. Minissian and Edward Shahady
Cardiometabolic Risk
CRS 2016: Cardiometabolic Risk and Related Comorbidities, Part 2
10/14/2016
Co-Chairs from the 2016 Cardiometabolic Risk Summit, Margo B. Minissian, PhDc, ACNP, CLS, AACC, FAHA and Edward Shahady, MD, FAAFP, ABCL,  discuss details from the panel discussions which take...
10/14/2016
Gastroenterology
Gastroenterology
Picking a Treatment Target: Is It as "Simple" as Mucosal Healing?
08/06/2018
08/06/2018
Endocrinology
Joel Heidelbaugh
Endocrinology
CRS 2015: Androgen Deficiency and Cardiometabolic Risk: Examining the Link to Improve Patient Care
09/25/2015
Faculty member Joel Heidelbaugh, MD, FAAFP, FACG, Clinical Professor, Departments of Family Medicine and Urology, University of Michigan Medical School; talks about testosterone replacement, when a...
09/25/2015